{
  "outline": [
    [
      1,
      "Literature Review: Living in the endosymbiotic world of Wolbachia- A centennial review."
    ],
    [
      1,
      "Living in the Endosymbiotic World of Wolbachia: A Centennial Review"
    ],
    [
      2,
      "Abstract"
    ],
    [
      2,
      "1. Introduction"
    ],
    [
      2,
      "2. Historical Development and Milestones"
    ],
    [
      3,
      "2.1 The Discovery (1924–1936)"
    ],
    [
      3,
      "2.2 The \"Quiet Years\" and the Renaissance (1936–1990s)"
    ],
    [
      3,
      "2.3 The Genomic and Translational Era (2000s–Present)"
    ],
    [
      2,
      "3. Key Concepts and Definitions"
    ],
    [
      3,
      "3.1 Reproductive Manipulations"
    ],
    [
      3,
      "3.2 Obligate Mutualism"
    ],
    [
      3,
      "3.3 Phylogeny and Supergroups"
    ],
    [
      2,
      "4. Current State-of-the-Art Methods and Techniques"
    ],
    [
      3,
      "4.1 Molecular Mechanisms of CI: The *cif* Genes"
    ],
    [
      3,
      "4.2 Genomic and Bioinformatic Approaches"
    ],
    [
      3,
      "4.3 Artificial Intelligence in Vector Control"
    ],
    [
      2,
      "5. Applications and Case Studies"
    ],
    [
      3,
      "5.1 Arbovirus Control: The World Mosquito Program (WMP)"
    ],
    [
      3,
      "5.2 Filariasis Elimination: The A-WOL Consortium"
    ],
    [
      3,
      "5.3 Agricultural Pest Control"
    ],
    [
      2,
      "6. Challenges and Open Problems"
    ],
    [
      3,
      "6.1 Ecological and Evolutionary Risks"
    ],
    [
      3,
      "6.2 Implementation Hurdles"
    ],
    [
      3,
      "6.3 Mechanistic Uncertainties"
    ],
    [
      2,
      "7. Future Research Directions"
    ],
    [
      3,
      "7.1 Synthetic Biology and Engineering"
    ],
    [
      3,
      "7.2 Climate Change Adaptation"
    ],
    [
      3,
      "7.3 Integration with Other Measures"
    ],
    [
      3,
      "7.4 Expanding the \"Wolbachia World\""
    ],
    [
      2,
      "8. Conclusion"
    ],
    [
      2,
      "References"
    ]
  ],
  "content": [
    {
      "heading": "Literature Review: Living in the endosymbiotic world of Wolbachia- A centennial review.",
      "level": 1,
      "content": "*Generated on: 2025-12-26 06:04:01*\n*Progress: [16/25]*\n*Saved to: /Users/joanna/Desktop/Literature_Reviews/Living_in_the_endosymbiotic_world_of_Wolbachia-_A_centennial_20251226_060401.md*\n---"
    },
    {
      "heading": "Living in the Endosymbiotic World of Wolbachia: A Centennial Review",
      "level": 1,
      "content": "**Key Points**\n*   **Centennial Milestone:** Discovered in 1924 by Hertig and Wolbach, *Wolbachia* has transitioned from an obscure entomological curiosity to a cornerstone of global public health strategies over the last century.\n*   **Global Impact:** The World Mosquito Program (WMP) has now protected over 13 million people across 14 countries by deploying *Wolbachia*-infected mosquitoes, significantly reducing dengue incidence (e.g., by 77% in Yogyakarta).\n*   **Mechanistic Breakthroughs:** The recent identification of the *cifA* and *cifB* genes has unraveled the molecular basis of Cytoplasmic Incompatibility (CI), though debate persists between \"toxin-antidote\" and \"host-modification\" models.\n*   **Therapeutic Targets:** The Anti-Wolbachia Consortium (A-WOL) is advancing novel antibiotics like Corallopyronin A to treat filariasis by targeting the obligate endosymbiont rather than the nematode host.\n*   **Future Frontiers:** Research is expanding into synthetic biology, AI-driven ecological modeling, and the discovery of new supergroups (V and W), positioning *Wolbachia* as a model organism for understanding endosymbiosis.\n\n***"
    },
    {
      "heading": "Abstract",
      "level": 2,
      "content": "The alphaproteobacterium *Wolbachia pipientis* represents one of the most successful endosymbionts in the biosphere, infecting an estimated 40–60% of all arthropod species and a significant proportion of filarial nematodes. As the scientific community marks the centennial of its discovery by Marshall Hertig and Simeon Burt Wolbach in 1924, this systematic review synthesizes a century of progress, from early morphological descriptions to the current genomic era. We examine the bacterium's diverse manipulations of host reproduction—most notably Cytoplasmic Incompatibility (CI)—and the molecular mechanisms governed by the *cifA* and *cifB* operons. The review highlights the translational leap from basic biology to applied vector control, detailing the successes of the World Mosquito Program in curbing arboviral transmission and the A-WOL consortium’s efforts to eliminate filariasis. Finally, we critically analyze emerging challenges, including resistance potential, ecological impacts, and the integration of artificial intelligence in modeling symbiotic spread, outlining a roadmap for the next century of *Wolbachia* research."
    },
    {
      "heading": "1. Introduction",
      "level": 2,
      "content": "Symbiosis is a fundamental driver of evolutionary complexity, and few organisms exemplify this better than the genus *Wolbachia*. These maternally inherited, obligate intracellular bacteria are arguably the most widespread endosymbionts in the animal kingdom [cite: 1, 2]. Residing primarily in the reproductive tissues of arthropods and nematodes, *Wolbachia* has evolved a stunning arsenal of adaptations that manipulate host biology to ensure its own transmission. These manipulations range from reproductive parasitism in insects to obligate mutualism in filarial worms [cite: 3, 4].\n\nThe year 2024 marks a significant milestone: the centennial of the initial discovery of *Wolbachia* in the common house mosquito, *Culex pipiens* [cite: 5, 6]. For decades following its discovery, the bacterium remained a biological curiosity. However, the last thirty years have witnessed a renaissance in *Wolbachia* research, driven by the realization that this endosymbiont can be harnessed to combat some of the world's most devastating diseases, including dengue, Zika, and river blindness [cite: 1, 7].\n\nThis review, titled \"Living in the Endosymbiotic World of Wolbachia,\" aims to provide a comprehensive, centennial analysis of the field. We synthesize literature regarding host range, phylogenetic diversity, and the molecular mechanisms of reproductive manipulation. Furthermore, we critically evaluate the state-of-the-art applications in vector control and agriculture, identify current research gaps, and propose future directions for the \"interdisciplinary science of this symbiosis\" [cite: 1, 8]."
    },
    {
      "heading": "2.1 The Discovery (1924–1936)",
      "level": 3,
      "content": "The history of *Wolbachia* research began in 1924 when entomologist Marshall Hertig and pathologist Simeon Burt Wolbach, working at Harvard University, identified a \"pleomorphic, rodlike, Gram-negative, intracellular organism\" in the ovaries and testes of *Culex pipiens* mosquitoes [cite: 5, 6]. Their collaboration was driven by a desire to distinguish pathogenic Rickettsia-like organisms from non-pathogenic symbionts. In 1936, Hertig formally described the species, proposing the name *Wolbachia pipientis* in honor of his colleague [cite: 5, 9]."
    },
    {
      "heading": "2.2 The \"Quiet Years\" and the Renaissance (1936–1990s)",
      "level": 3,
      "content": "Following its description, *Wolbachia* received relatively little attention until 1971, when Janice Yen and A. Ralph Barr at UCLA made a pivotal discovery. They observed that crosses between certain populations of *Culex* mosquitoes resulted in no offspring—a phenomenon known as Cytoplasmic Incompatibility (CI). They linked this reproductive incompatibility directly to the presence of *Wolbachia*, demonstrating that the bacteria could kill eggs when sperm from an infected male fertilized an uninfected egg [cite: 5, 9]."
    },
    {
      "heading": "2.3 The Genomic and Translational Era (2000s–Present)",
      "level": 3,
      "content": "The sequencing of the *Wolbachia* genome from *Drosophila melanogaster* (*w*Mel) in 2004, followed by the strain infecting *Brugia malayi* (*w*Bm) in 2005, revolutionized the field [cite: 5, 10]. These genomic insights paved the way for understanding the molecular basis of symbiosis. Simultaneously, researchers began to explore the bacterium's potential for disease control. A landmark moment occurred when it was discovered that *Wolbachia* infection blocks the replication of RNA viruses like dengue and Chikungunya in mosquitoes [cite: 11, 12]. This discovery laid the foundation for the World Mosquito Program (WMP) and other global initiatives that are now deploying *Wolbachia* at scale [cite: 13, 14]."
    },
    {
      "heading": "3.1 Reproductive Manipulations",
      "level": 3,
      "content": "*Wolbachia* is renowned as a \"master manipulator\" of host reproduction, employing four primary phenotypes to increase the frequency of infected females in the population [cite: 2, 9]:\n1.  **Cytoplasmic Incompatibility (CI):** The most common phenotype. Sperm from *Wolbachia*-infected males are modified such that they cannot successfully fertilize eggs from uninfected females (or females with an incompatible strain). However, if the female is infected with the same strain, she \"rescues\" the embryo, allowing normal development. This gives infected females a reproductive advantage [cite: 1, 15].\n2.  **Male Killing:** The bacterium kills infected male embryos during development, redirecting resources to female siblings who transmit the bacteria [cite: 9].\n3.  **Feminization:** Genetic males are converted into functional females, thereby increasing the number of transmitting hosts [cite: 1, 16].\n4.  **Parthenogenesis:** *Wolbachia* induces asexual reproduction in haplodiploid species (like wasps), allowing females to produce female offspring without mating [cite: 1, 16]."
    },
    {
      "heading": "3.2 Obligate Mutualism",
      "level": 3,
      "content": "In contrast to the reproductive parasitism seen in arthropods, *Wolbachia* maintains an obligate mutualistic relationship with filarial nematodes (e.g., *Onchocerca volvulus*, *Wuchereria bancrofti*). In these hosts, the bacteria are essential for nematode embryogenesis, development, and survival. Elimination of *Wolbachia* via antibiotics results in the sterilization and eventual death of the worm, a concept that forms the basis of anti-filarial therapies [cite: 4, 17]."
    },
    {
      "heading": "3.3 Phylogeny and Supergroups",
      "level": 3,
      "content": "*Wolbachia* strains are classified into \"supergroups\" (clades) designated by letters. Historically, supergroups A and B (found in arthropods) and C and D (found in nematodes) were the most studied. As of 2024, the diversity has expanded significantly to include supergroups A–F, H–Q, and S–U [cite: 18, 19].\n*   **Recent Discoveries:** In 2023, two novel strains isolated from cat fleas (*Ctenocephalides felis*) were found to be genetically distinct from all known lineages, leading to the designation of new supergroups **V** (*w*CfeJ) and **W** (*w*CfeT) [cite: 18]. This continuous discovery of new lineages highlights the immense and under-sampled diversity of the genus."
    },
    {
      "heading": "4.1 Molecular Mechanisms of CI: The *cif* Genes",
      "level": 3,
      "content": "A major breakthrough in recent years was the identification of the genes responsible for CI, located in the eukaryotic association module of prophage WO (a bacteriophage infecting *Wolbachia*). These genes are termed *cifA* and *cifB* (Cytoplasmic Incompatibility Factors) [cite: 1, 20].\n*   **Two-Gene Operon:** In the *w*Mel strain, *cifA* and *cifB* form an operon. *cifB* is generally identified as the \"toxin\" or modifier that causes embryonic lethality, while *cifA* acts as the \"antidote\" or rescue factor [cite: 20, 21].\n*   **Mechanistic Models:** Two competing models currently describe CI:\n    1.  **Toxin-Antidote (TA) Model:** Proposes that *cifB* (toxin) is paternally transmitted to the egg, where it disrupts development unless bound and neutralized by maternally provided *cifA* [cite: 21, 22, 23].\n    2.  **Host-Modification (HM) Model:** Suggests that *cif* proteins modify sperm integrity (e.g., disrupting the histone-to-protamine transition) during spermatogenesis. The proteins themselves may not need to be present in the embryo; rather, the \"rescue\" involves reversing this modification [cite: 22, 24, 25]. Recent structural studies of CinA-CinB complexes have provided evidence supporting aspects of the TA model, but the debate remains active [cite: 21, 25]."
    },
    {
      "heading": "4.2 Genomic and Bioinformatic Approaches",
      "level": 3,
      "content": "Modern *Wolbachia* research relies heavily on high-throughput sequencing and phylogenomics. Techniques such as Average Nucleotide Identity (ANI) and digital DNA-DNA hybridization (dDDH) are now standard for classifying new strains and supergroups [cite: 18, 26]. Furthermore, bibliometric analyses using tools like VOSViewer are being used to map the global landscape of *Wolbachia* research, identifying emerging themes like \"arboviruses\" and \"vector control\" [cite: 11, 27]."
    },
    {
      "heading": "4.3 Artificial Intelligence in Vector Control",
      "level": 3,
      "content": "The integration of Artificial Intelligence (AI) represents a new frontier. AI-supported mathematical models are now used to forecast disease control outcomes, simulate mating scenarios between infected and wild mosquitoes, and predict the impact of climate change on *Wolbachia* spread. These models are crucial for designing cost-effective release strategies [cite: 28, 29]."
    },
    {
      "heading": "5.1 Arbovirus Control: The World Mosquito Program (WMP)",
      "level": 3,
      "content": "The most prominent application of *Wolbachia* is the \"population replacement\" strategy to control dengue, Zika, and chikungunya. This method involves releasing male and female *Aedes aegypti* infected with the *w*Mel strain. The bacteria block viral replication, and CI drives the spread of *Wolbachia* through the local mosquito population [cite: 15, 30].\n\n*   **Impact:** As of 2024, the WMP has deployed *Wolbachia* in 14 countries, protecting an estimated 13.3 to 13.5 million people [cite: 13].\n*   **Efficacy:**\n    *   **Indonesia:** A gold-standard randomized controlled trial in Yogyakarta demonstrated a **77% reduction** in dengue incidence and an **86% reduction** in hospitalizations in *Wolbachia*-treated areas [cite: 31, 32].\n    *   **Latin America:** In the Aburrá Valley, Colombia, dengue incidence dropped by **95–97%** following the establishment of *Wolbachia* [cite: 33, 34]. In Niterói, Brazil, cases dropped by 90% [cite: 34].\n    *   **Australia:** Dengue has been effectively eliminated as a public health concern in Far North Queensland [cite: 32]."
    },
    {
      "heading": "5.2 Filariasis Elimination: The A-WOL Consortium",
      "level": 3,
      "content": "The Anti-Wolbachia (A-WOL) Consortium focuses on targeting the mutualistic *Wolbachia* in filarial nematodes to treat diseases like onchocerciasis (river blindness) and lymphatic filariasis [cite: 17].\n*   **Strategy:** Killing the bacteria sterilizes the adult worms and eventually causes their death (macrofilaricidal effect), offering a superior therapeutic outcome compared to standard anti-filarial drugs that only target microfilariae [cite: 35, 36].\n*   **Drug Development:**\n    *   **Doxycycline:** Effective but requires a 4–6 week course, which is impractical for mass drug administration (MDA) and contraindicated in children/pregnancy [cite: 37, 38].\n    *   **Corallopyronin A (CorA):** A myxobacterial antibiotic that inhibits bacterial RNA polymerase. Preclinical studies show it is highly effective, potentially allowing for shorter treatment regimens (7 days). It is currently advancing toward clinical trials [cite: 36, 37, 39].\n    *   **ABBV-4083:** Another promising candidate that has entered clinical trials, designed to be effective in short-course regimens [cite: 36, 40]."
    },
    {
      "heading": "5.3 Agricultural Pest Control",
      "level": 3,
      "content": "While less developed than mosquito control, *Wolbachia*-based strategies are being explored for agricultural pests. The \"Incompatible Insect Technique\" (IIT) uses *Wolbachia* to induce sterility in pests like planthoppers and fruit flies. However, establishing stable transinfected lines in these pests remains a significant bottleneck compared to mosquitoes [cite: 41, 42]."
    },
    {
      "heading": "6.1 Ecological and Evolutionary Risks",
      "level": 3,
      "content": "The release of *Wolbachia*-infected mosquitoes constitutes a massive ecological intervention. Concerns include:\n*   **Resistance:** The potential for viruses to evolve resistance to *Wolbachia*-mediated blocking, or for mosquitoes to evolve resistance to CI [cite: 28].\n*   **Replacement Failure:** In some environments, such as extreme heat, *Wolbachia* strains (like *w*Mel) may lose density or fail to persist, compromising the virus-blocking effect [cite: 15, 43].\n*   **Non-target Effects:** While generally considered safe, the long-term ecological consequences of replacing wild vector populations require continuous monitoring [cite: 44]."
    },
    {
      "heading": "6.2 Implementation Hurdles",
      "level": 3,
      "content": "*   **Malaria Vectors:** Unlike *Aedes*, *Anopheles* mosquitoes (malaria vectors) are not naturally infected with *Wolbachia*. Transinfecting them is technically difficult, and the bacteria can impose fitness costs that hinder spread. Only a few stable lines (e.g., *An. stephensi* with *w*AlbB) have been established [cite: 43, 45, 46].\n*   **Scale and Cost:** While cost-effective in the long term, the initial phase of rearing and releasing mosquitoes requires substantial infrastructure and community engagement [cite: 30, 45]."
    },
    {
      "heading": "6.3 Mechanistic Uncertainties",
      "level": 3,
      "content": "Despite the discovery of *cifA* and *cifB*, the precise biochemical interaction between these proteins and the host sperm chromatin remains a subject of debate. Understanding whether the mechanism is a \"lock-and-key\" toxin-antidote system or a more complex host modification is crucial for predicting the stability of CI and engineering new strains [cite: 21, 25]."
    },
    {
      "heading": "7.1 Synthetic Biology and Engineering",
      "level": 3,
      "content": "The future of *Wolbachia* research lies in synthetic biology. Researchers aim to engineer the *Wolbachia* genome to enhance desirable traits, such as stronger virus blocking or better thermal tolerance. This includes manipulating the *cif* genes to create \"super-CI\" strains that can spread more aggressively or induce sterility in new pest species [cite: 29, 47]."
    },
    {
      "heading": "7.2 Climate Change Adaptation",
      "level": 3,
      "content": "As climate change alters mosquito habitats and breeding cycles, *Wolbachia* interventions must adapt. Future research will focus on identifying or engineering strains that remain robust under higher temperatures and fluctuating environmental conditions [cite: 29, 48]."
    },
    {
      "heading": "7.3 Integration with Other Measures",
      "level": 3,
      "content": "*Wolbachia* is not a silver bullet. Future strategies will likely involve Integrated Vector Management (IVM), combining *Wolbachia* releases with traditional methods (bed nets, insecticides) and novel tools like gene drives or sterile insect techniques (SIT) [cite: 29, 46]."
    },
    {
      "heading": "7.4 Expanding the \"Wolbachia World\"",
      "level": 3,
      "content": "With the discovery of supergroups V and W, and the detection of *Wolbachia* in diverse hosts like cat fleas and spiders, the known host range continues to grow. Genomic surveys will likely reveal that we have only scratched the surface of *Wolbachia* diversity and its functional roles in non-model organisms [cite: 18]."
    },
    {
      "heading": "8. Conclusion",
      "level": 2,
      "content": "A century after Hertig and Wolbach peered through a microscope at a *Culex* ovary, the organism they described has transcended its status as a mere endosymbiont to become a \"biological archetype\" for symbiosis and a powerful tool for global health [cite: 1]. The transition from basic observation to the protection of millions of people from dengue represents one of the great success stories of translational biology.\n\nHowever, living in the *Wolbachia* world is complex. It requires navigating the fine balance between parasitism and mutualism, understanding intricate molecular handshakes like those of *cifA* and *cifB*, and managing large-scale ecological interventions. As we enter the second century of *Wolbachia* research, the field stands at the convergence of genomics, synthetic biology, and public health. The challenges of resistance, climate change, and expanding host ranges remain, but the potential to harness this \"master manipulator\" to solve human and agricultural problems has never been greater."
    }
  ],
  "references": [
    "[cite: 1] Kaur, R., et al. (2021). Living in the endosymbiotic world of Wolbachia: A centennial review. *Cell Host & Microbe*, 29(6), 879–893. [cite: 1, 2, 3, 8, 49]",
    "[cite: 11] Sarwar, M. S., et al. (2025). Comprehensive review of Wolbachia research (1936–2024): Global landscape, mapping progress and themes. *Parasite Epidemiology and Control*, 30, e00438. [cite: 11, 27]",
    "[cite: 3] Taylor, M. J., et al. (2005). Wolbachia bacterial endosymbionts of filarial nematodes. *Advances in Parasitology*, 60, 245–284. [cite: 50]",
    "[cite: 2] Werren, J. H., et al. (2008). Wolbachia: master manipulators of invertebrate biology. *Nature Reviews Microbiology*, 6(10), 741–751. [cite: 10, 15]",
    "[cite: 15] Minwuyelet, A., et al. (2023). Symbiotic Wolbachia in mosquitoes and its role in reducing the transmission of mosquito-borne diseases: updates and prospects. *Frontiers in Microbiology*, 14, 1267832. [cite: 15]",
    "[cite: 16] Higa, L. M., & Taniguchi, M. (2023). Wolbachia in the Hawaiian Drosophilidae. *Genes*, 14(8), 1545. [cite: 16]",
    "[cite: 50] Dedeine, F., et al. (2003). Insights into Wolbachia obligatory symbiosis. *Insect Symbiosis*, 267–282. [cite: 50]",
    "[cite: 51] Lindsey, A. R., et al. (2018). Evolutionary Genetics of Cytoplasmic Incompatibility Genes cifA and cifB in Prophage WO of Wolbachia. *Genome Biology and Evolution*. [cite: 52]",
    "[cite: 5] Hertig, M., & Wolbach, S. B. (1924). Studies on Rickettsia-Like Micro-Organisms in Insects. *The Journal of Medical Research*, 44(3), 329–374. [cite: 5, 6]",
    "[cite: 4] Taylor, M. J., et al. (2010). The discovery of Wolbachia in arthropods and nematodes – a historical perspective. *Clinical Microbiology and Infection*. [cite: 4, 53]",
    "[cite: 12] Walker, T., et al. (2011). The wMel Wolbachia strain blocks dengue and invades caged Aedes aegypti populations. *Nature*, 476, 450–453. [cite: 15]",
    "[cite: 9] Yen, J. H., & Barr, A. R. (1971). New hypothesis of the cause of cytoplasmic incompatibility in Culex pipiens. *Nature*. [cite: 5, 9]",
    "[cite: 6] The Scientist. (2024). Wolbachia Turns 100: The Journey of a Triumphant Endosymbiont. [cite: 6]",
    "[cite: 8] Kaur, R. (2021). Living in the endosymbiotic world of Wolbachia: A centennial review. *Penn State University*. [cite: 8]",
    "[cite: 49] Kaur, R., et al. (2021). Living in the endosymbiotic world of Wolbachia: A centennial review. *PubMed*. [cite: 49]",
    "[cite: 47] Kaur, R. (n.d.). Rupinder Kaur Profile. *University of Illinois Chicago*. [cite: 47]",
    "[cite: 54] Kaur, R., et al. (2021). Living in the endosymbiotic world of Wolbachia: A centennial review. *ORCID*. [cite: 54]",
    "[cite: 27] Sarwar, M. S., et al. (2025). Comprehensive review of Wolbachia research (1936–2024). *PubMed*. [cite: 27]",
    "[cite: 7] Gigazine. (2023). Mosquitoes infected with Wolbachia significantly reduce dengue fever. [cite: 7]",
    "[cite: 28] Iftikhar, A., et al. (2024). Wolbachia-Based Approaches to Controlling Mosquito-Borne Viral Threats: Innovations, AI Integration, and Future Directions. *Pathogens*, 16(12). [cite: 28, 29, 48]",
    "[cite: 45] Mushtaq, I., et al. (2024). Updates on traditional methods for combating malaria and emerging Wolbachia-based interventions. *Frontiers in Cellular and Infection Microbiology*, 14. [cite: 45]",
    "[cite: 46] Ahmad, M., et al. (2024). Wolbachia-based interventions for malaria control. *PubMed*. [cite: 46]",
    "[cite: 45] Mushtaq, I., et al. (2024). Updates on traditional methods for combating malaria. *Frontiers*. [cite: 45]",
    "[cite: 55] Chamchod, F. (2023). Modeling the Spread of Wolbachia in Anopheles Mosquito Populations. *Tropical Medicine and Infectious Disease*, 8(3), 162. [cite: 55]",
    "[cite: 43] MESA Malaria. (n.d.). Exploring Wolbachia for malaria control. [cite: 43]",
    "[cite: 56] MESA Malaria. (n.d.). Wolbachia-based interventions for malaria vector control. [cite: 56]",
    "[cite: 17] A-WOL Consortium. (n.d.). About A-WOL. [cite: 17]",
    "[cite: 57] A-WOL Consortium. (n.d.). Our Consortium Projects. [cite: 57]",
    "[cite: 35] Liverpool School of Tropical Medicine. (n.d.). A-WOL Projects. [cite: 35]",
    "[cite: 39] University of Bonn. (2024). A-WOL team awarded 2024 Horizon Prize. [cite: 39]",
    "[cite: 40] Taylor, M. J., et al. (2021). The A·WOL consortium: a partnership for the discovery and development of anti-Wolbachia medicines. *Trends in Parasitology*. [cite: 40]",
    "[cite: 13] World Mosquito Program. (2024). Annual Review 2024. [cite: 13]",
    "[cite: 31] Wellcome Trust. (2025). World Mosquito Program disease control. [cite: 31]",
    "[cite: 32] World Mosquito Program. (2024). Impact of the Wolbachia method. [cite: 32]",
    "[cite: 33] World Mosquito Program. (2024). Annual Review Hub. [cite: 33]",
    "[cite: 34] World Mosquito Program. (2024). Annual Review 2024 PDF. [cite: 34]",
    "[cite: 20] Needleman, A., et al. (2024). Comparative genomics of the Wolbachia CIF system. *PubMed*. [cite: 20]",
    "[cite: 58] LePage, D., et al. (2023). Widespread occurrence of cif genes in bacterial symbionts. *PLOS Genetics*. [cite: 58]",
    "[cite: 21] Wang, C., et al. (2021). Structural basis of the CinA-CinB complex. *PNAS*, 118(41). [cite: 21, 23]",
    "[cite: 24] Kaur, R., et al. (2025). Cif proteins alter sperm development. *Proceedings of the Royal Society B*. [cite: 24]",
    "[cite: 59] Shropshire, J. D., et al. (2021). The Two-by-One model of cytoplasmic incompatibility. *Genetics*, 217(1). [cite: 59]",
    "[cite: 18] Sharma, A. K., & Som, A. (2023). Assigning new supergroups V and W to the Wolbachia diversity. *Bioinformation*, 19(3), 336–340. [cite: 18, 26]",
    "[cite: 19] Sharma, A. K., & Som, A. (2023). Wolbachia supergroups list. *PubMed*. [cite: 19]",
    "[cite: 60] Wannassi, T., et al. (2024). List of Wolbachia strains. *ResearchGate*. [cite: 60]",
    "[cite: 26] Sharma, A. K., & Som, A. (2023). Assigning new supergroups V and W. *Bioinformation PDF*. [cite: 26]",
    "[cite: 10] Wang, G. H., et al. (2020). Phylogenomic analysis of Wolbachia strains. *Genome Biology and Evolution*. [cite: 10]",
    "[cite: 18] Sharma, A. K., & Som, A. (2023). Wolbachia supergroups V and W. *PubMed*. [cite: 18]",
    "[cite: 19] Sharma, A. K., & Som, A. (2023). Wolbachia supergroups V and W. *PMC*. [cite: 19]",
    "[cite: 26] Sharma, A. K., & Som, A. (2023). Wolbachia supergroups V and W. *Bioinformation*. [cite: 26]",
    "[cite: 61] Driscoll, T. P., et al. (2020). Evolution of Wolbachia mutualism and reproductive parasitism. *ResearchGate*. [cite: 61]",
    "[cite: 62] Gerth, M., et al. (2023). Wolbachia supergroup F. *Frontiers in Microbiology*. [cite: 62]",
    "[cite: 31] Wellcome Trust. (2025). World Mosquito Program impact. [cite: 31]",
    "[cite: 32] World Mosquito Program. (2024). Impact metrics. [cite: 32]",
    "[cite: 63] World Mosquito Program. (2024). Homepage. [cite: 63]",
    "[cite: 13] World Mosquito Program. (2024). Annual Review 2024 Text. [cite: 13]",
    "[cite: 34] World Mosquito Program. (2024). Annual Review 2024 Full Report. [cite: 34]",
    "[cite: 5] Wikipedia. (n.d.). Wolbachia History. [cite: 5]",
    "[cite: 4] Washington University in St. Louis. (n.d.). The discovery of Wolbachia. [cite: 4]",
    "[cite: 53] Taylor, M. J., et al. (2010). The Discovery of Wolbachia. *ResearchGate*. [cite: 53]",
    "[cite: 64] Karger. (2007). Wolbachia discovery history. [cite: 64]",
    "[cite: 6] The Scientist. (2024). Wolbachia Turns 100. [cite: 6]",
    "[cite: 22] Harumoto, T., & Fukatsu, T. (2022). Perplexing dynamics of Wolbachia proteins for cytoplasmic incompatibility. *PLOS Biology*. [cite: 22]",
    "[cite: 25] Shropshire, J. D., et al. (2022). The incipient, prefertilization events in CI. *PLOS Biology*. [cite: 25]",
    "[cite: 23] Wang, C., et al. (2021). Toxin-antidote model of CI. *PNAS*. [cite: 23]",
    "[cite: 52] Lindsey, A. R., et al. (2018). Evolutionary Genetics of cifA and cifB. *ResearchGate*. [cite: 52]",
    "[cite: 65] Beckmann, J. F., et al. (2019). The Toxin-Antidote Model of Cytoplasmic Incompatibility. *ResearchGate*. [cite: 65]",
    "[cite: 37] Schiefer, A., et al. (2020). Corallopyronin A for filariasis. *PubMed*. [cite: 37]",
    "[cite: 36] Krome, A. K., et al. (2022). Corallopyronin A and ABBV-4083. *Frontiers in Tropical Diseases*. [cite: 36, 38]",
    "[cite: 66] EKFS. (n.d.). Production of Corallopyronin A. [cite: 66]",
    "[cite: 67] Jamabo, M., et al. (2025). Clinical trials in lymphatic filariasis. *BioRxiv*. [cite: 67]",
    "[cite: 38] Krome, A. K., et al. (2022). Corallopyronin A PDF. *Frontiers*. [cite: 38]",
    "[cite: 29] Branda, F., et al. (2024). Wolbachia-Based Approaches to Controlling Mosquito-Borne Viral Threats. *ResearchGate*. [cite: 29]",
    "[cite: 5] Wikipedia. (n.d.). Wolbachia synthetic biology. [cite: 5]",
    "[cite: 68] Kaveti, A. (2021). The Future of Synthetic Biology. *SBYI Review*. [cite: 68]",
    "[cite: 69] French, C. E., et al. (2019). Synthetic biology and its applications. *PMC*. [cite: 69]",
    "[cite: 28] Iftikhar, A., et al. (2024). Wolbachia research challenges. *PMC*. [cite: 28]",
    "[cite: 70] Salama, L. A., et al. (2024). Using Wolbachia Bacteria to Control Mosquito-Borne Disease. *ResearchGate*. [cite: 70]",
    "[cite: 44] Ross, P. A., et al. (2024). Safety of Wolbachia-Based Control Strategies. *MDPI*. [cite: 44]",
    "[cite: 14] Grand Challenges. (2016). Biological Vector Control. [cite: 14]",
    "[cite: 41] Gong, J. T., et al. (2023). Wolbachia-based strategies for control of agricultural pests. *Current Opinion in Insect Science*. [cite: 41]",
    "[cite: 71] African Genetic Biocontrol Consortium. (2023). Wolbachia for agricultural pests. [cite: 71]",
    "[cite: 42] Gong, J. T., et al. (2023). Wolbachia applications in planthoppers. *Frontiers in Microbiology*. [cite: 42]",
    "[cite: 72] Gong, J. T., et al. (2023). Wolbachia agricultural pest control. *ResearchGate*. [cite: 72]",
    "[cite: 73] Gong, J. T., et al. (2023). Wolbachia pest control. *PMC*. [cite: 73]",
    "[cite: 27] Sarwar, M. S., et al. (2025). Wolbachia research methods. *PubMed*. [cite: 27]",
    "[cite: 30] Ant, T. H., et al. (2024). Current Status of Mosquito Handling. *PMC*. [cite: 30]",
    "[cite: 48] Branda, F., et al. (2024). Wolbachia and climate change. *Butantan Repository*. [cite: 48]",
    "[cite: 74] Ros, V. I., et al. (2009). Wolbachia supergroups list. *Applied and Environmental Microbiology*. [cite: 74]",
    "[cite: 19] Sharma, A. K., & Som, A. (2023). Wolbachia supergroups list. *PMC*. [cite: 19]",
    "[cite: 26] Sharma, A. K., & Som, A. (2023). Wolbachia supergroups list. *Bioinformation PDF*. [cite: 26]",
    "[cite: 10] Wang, G. H., et al. (2020). Wolbachia supergroups list. *PMC*. [cite: 10]"
  ]
}